Search the Newsreel

FDA grants fast track status to Oncolytics’ anal cancer therapy By Investing.com

Oncolytics Biotech Inc. (NASDAQ: ONCY) has received Fast Track designation from the FDA for pelareorep combined with a checkpoint inhibitor to treat inoperable, recurrent, or metastatic anal canal squamous cell carcinoma. This designation accelerates development and review for therapies addressing serious diseases with unmet …

Investigational anal cancer therapy posts 30% response rate

Oncolytics Biotech (Nasdaq: ONCY) has received U.S. FDA Fast Track designation for pelareorep in combination with a checkpoint inhibitor for the treatment of advanced anal cancer. This designation is based on encouraging data from the GOBLET study, which showed an objective response rate of …

Oncolytics receives FDA Fast Track for pelareorep plus checkpoint inhibitor in second-line+ anal cancer

Oncolytics Biotech (ONCY) has secured FDA Fast Track designation for its drug pelareorep combined with a checkpoint inhibitor for treating advanced squamous cell carcinoma of the anal canal (SCAC). This designation is based on promising data from the GOBLET study, which showed a 30% …

Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer

Oncolytics Biotech has received Fast Track designation from the FDA for its immunotherapy pelareorep, combined with a checkpoint inhibitor, to treat advanced anal cancer that has progressed after first-line therapy. This marks the third Fast Track designation for pelareorep in gastrointestinal cancers, highlighting its …

Samsung Biologics to acquire PolyPeptide in $1.81bn cash deal

Samsung Biologics is set to acquire PolyPeptide Group through an all-cash public tender offer valued at SFr1.46bn ($1.81bn). The proposed offer is set at SFr44.31 per share for 100% of PolyPeptide's fully diluted share capital, excluding treasury shares. Completion of the deal is anticipated …

Bhansali Engineering Polymers jumps as Q1 PAT rises 43% YoY

Polymetals Resources (ASX:POL) Generates A$39.39M Revenue—But Can It Overcome Profitability Challenge?

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion. Strong transaction support, with a unanimous recommendation from …

Gulshan Polyols receives ₹5 Cr incentive under NEIDS from DPIIT

Earnings Beat: Polycab India Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026

Polyrizon Ltd. shareholders approved a new executive compensation policy on July 13, 2026, during their annual general meeting in Raanana. The policy, effective for three years, includes base salary, benefits, cash bonuses, and equity awards, with variable pay capped at 95% of total compensation …

Bhansali Engineering Polymers Q1 Results: Net profit jumps 42.9% YoY, revenue up 53.3%

PolyPid (PYPD) awards CFO 49,000 stock options at $4.46

PolyPid Ltd. (PYPD) reported that its Chief Financial Officer, Jonathan Missulawin, was granted 49,000 stock options on May 11, 2026. These options have an exercise price of $4.46 per share, an exercise date of August 11, 2026, and expire on May 11, 2036. The …

PolyPid (NASDAQ: PYPD) grants 46,000 stock options to U.S. COO

PolyPid Ltd. (NASDAQ: PYPD) has granted its U.S. Chief Operating Officer, Ori Warshavsky, an option to purchase 46,000 ordinary shares with an exercise price of $4.46 per share. These options will vest quarterly from May 11, 2026, to May 11, 2030, and are set …

PolyPid (PYPD) grants director Dror-Darwish Nir 9,132 stock options at $4.46

PolyPid Ltd. (PYPD) director Dror-Darwish Nir was granted 9,132 stock options at an exercise price of $4.46 per share. These options will vest quarterly starting July 15, 2026, until April 15, 2030, and are set to expire on July 15, 2036. This transaction is …

Frontier tech research, news & data

The article reports on an insider transaction for PolyPid Ltd. filed on July 17, 2026. It also mentions a research report titled "The Power Delivery Gap" which analyzes the US grid's capacity to deliver renewable and firm gas power based on interconnection queue data.

Polycab India extends fall, down 5% in two days post Q1 results

Profit booking in Polycab shares after Q1 earnings: Brokerages share price targets, outlook

Polycab India’s Q1 growth is solid. Now volumes need a recharge

Polycab stock falls 4% today despite Q1 earnings beat; Jefferies, HSBC retain Buy calls

Polycab India shares fall 4% despite strong Q1 earnings, profit jumps 33% YoY

Polycab India Ltd (BOM:542652) Q1 2027 Earnings Call Highlights: Record Revenue and Profit ...

Polycab India Q1 result: Profit rises 33%, revenue grows 39% to ₹8,210 cr

Polycab India Q1 FY27 Results: PAT Rises 33% YoY, Revenue Jumps 39%

Polycab India Q1 Results: Profit Rises 33%, Revenue Climbs 39% Even As Shares Slip

PolyPid Ltd. (PYPD) boosts option pool by 1.5M shares and clears CEO grant

PolyPid Ltd. (PYPD) held its Annual and Extraordinary General Meeting of Shareholders on July 15, 2026, where all four proposals were approved, including the re-election of auditors and directors, amendments to non-executive directors' option grants, and an option grant for CEO Dikla Czaczkes Akselbrad. …

Polymetals Resources (ASX:POL) Shares Ease as Investors Take Profits From the Mining Stock

Polymetals (ASX:POL) revenue jumps 65% as Endeavor turns cash machine

Dividend Investors: Don't Be Too Quick To Buy Bhansali Engineering Polymers Limited (NSE:BEPL) For Its Upcoming Dividend

Technical Olympic S A : ACQUISITION OF OWN SHARES

Polymetals Resources (ASX:POL) Gains Over 5%: Is This Silver Producer Worth Watching?

Olympia Financial Group declares $0.50 monthly dividend

Polymetals Resources Insider Confidence Rewarded, Stock Hits AU$255m Market Cap

Tijaria Polypipes board to meet on July 9 to consider auditor appointment

Polyplex Corporation Share Price Target 2026: Bull Case Rs 1,180

PPGN Prognose — Kursziel für 2027